Gene Therapy Press Releases

PARTNERS4ACCESS has announced the appointment of Akshay Kumar as Partner to lead its rapidly expanding global strategic market access team.

Grass-roots group raises $2.35 million through community events

S. Florida-Based Organization and Its Supporters Honor Those Who Have Helped Drive Therapy Breakthroughs Together

Partners4Access has announced their gold sponsorship of the biotech industry conference World Orphan Drug Congress (WODC) USA. The event will take place at The Gaylord National Harbor Hotel in Oxon Hill, Maryland between April 10-12, 2019.

Sophie Schmitz, Managing Partner of Partners4Access is to lead two educational sessions on gene therapy at the Academy of Managed Care Pharmacy (AMCP)'s annual meeting between March 25-28, 2019.

GreatPoint Ventures, a leading San Francisco based venture capital firm, announced the closing of an investment in Guide Therapeutics, Inc. (GuideRx), a developer of lipid nanoparticles (LNPs) for delivery of therapeutics for gene therapy.

S. Florida-Based Organization Hosts Annual "Sweetness and Laughter" Gala & "See the Light" Awards Ceremony March 16th in Delray Beach

SMi Group are delighted to welcome expertise from a senior panel of big pharma and biotech organisations and regulatory bodies, at the most talked about conference on Cell & Gene Therapy 2018 launching this October in the City of London, UK.

The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike.

As part of its business expansion activities, Partners4Access' Sophie Schmitz will be attending industry group, BioIndustry Association (BIA)'s Summer Networking Reception on Thursday, July 12.

Aldevron, a leading global provider of plasmid DNA and mRNA manufacturing, protein production and antibody discovery services, and Odylia, a nonprofit organization working to develop treatments for ultra-rare ocular diseases using gene therapy, have...

Donation in honor of Hunter Syndrome advocate Simon Ibell who passed away in 2017 at the age of 39 due to complications from Hunter Syndrome

Free webinar will be held on Wednesday April 4 2018 at 17:00 GMT/1200 EST/9:00 PST.

RNCOS has recently added a new Market Research Report titled, "Global & US Gene Therapy Market Forecast to 2020" to its report gallery. This report provides extensive research on Global & US Gene Therapy Market.

The new Maxygen brings together scientists experienced in the application of molecular breeding paired with an accomplished leader in contract manufacturing to offer custom directed evolution programs across all sectors of biotech.

Vector Production and Active IND Meet Major Milestones in Foundation-Scientists Collaboration to Develop an Experimental Therapy for Young Boys with a Rare Dementia-Like Disease

As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from the transferred FVIII gene.

Families Are Making A Cure A Reality for the Rare Disease Hunter Syndrome / MPS II

Partners4Access (P4A), the specialists in orphan drug access, are launching a weekly newsletter focussing on key developments in the rare diseases and orphan drugs market access landscape.

Sophie Schmitz, Managing Partner of Partners4Access, the specialists in orphan drug access, is presenting at the 8th annual meeting of the World Orphan Drug Congress in Barcelona on November 15, 2017 on Gene Therapy.

Partners4Access (P4A) the specialists in orphan drug access, are presenting 3 posters at the International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) 20th European Congress in Glasgow from 4th to 8th November 2017.